about
Idiopathic Pulmonary Fibrosis: Treatment and PrognosisYear in review 2016: Interstitial lung disease, pulmonary vascular disease, pulmonary function, paediatric lung disease, cystic fibrosis and sleep.A new era in idiopathic interstitial pneumonias: Epilogue to a review series.Nintedanib for the treatment of idiopathic pulmonary fibrosis.FGF9 prevents pleural fibrosis induced by intrapleural adenovirus injection in mice.Olodaterol shows anti-fibrotic efficacy in in vitro and in vivo models of pulmonary fibrosis.
P2860
description
2016 nî lūn-bûn
@nan
2016 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Pharmacological management of IPF
@ast
Pharmacological management of IPF
@en
Pharmacological management of IPF
@nl
type
label
Pharmacological management of IPF
@ast
Pharmacological management of IPF
@en
Pharmacological management of IPF
@nl
prefLabel
Pharmacological management of IPF
@ast
Pharmacological management of IPF
@en
Pharmacological management of IPF
@nl
P2093
P2860
P356
P1433
P1476
Pharmacological management of IPF
@en
P2093
Aurelien Justet
Bruno Crestani
Effrosyni D Manali
Guillaume Beltramo
Paolo Spagnolo
Pauline Pradère
P2860
P304
P356
10.1111/RESP.12778
P407
P577
2016-04-12T00:00:00Z